Universe Pharmaceuticals Inc
3 hedge funds and large institutions have $93.7K invested in Universe Pharmaceuticals Inc in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
290% more capital invested
Capital invested by funds: $24K → $93.7K (+$69.7K)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$32.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$9.27K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Acadian Asset Management
Boston,
Massachusetts
| $55K | +$32.4K | +7 | +175% |
|
2
Renaissance Technologies
New York
| $32K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $6.67K | -$9.27K | -2 | -67% |
|
UPC Hedge Fund Activity: Q4 2022 in Review
3 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Universe Pharmaceuticals Inc (UPC) for Q4 2022, worth a combined $93.7K — up 290% from $24K a quarter earlier.
Fund positioning in UPC was balanced in Q4 2022: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $32.4K. The largest seller was UBS Group, cutting an estimated $9.27K.
- 3 institutional investors held Universe Pharmaceuticals Inc (UPC) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $93.7K of Universe Pharmaceuticals Inc stock for Q4 2022, up 290% quarter-over-quarter.
- 0 funds opened new Universe Pharmaceuticals Inc positions in Q4 2022 and 0 closed out.
- The largest Universe Pharmaceuticals Inc buyer in Q4 2022 was Acadian Asset Management, an estimated $32.4K added.
- The largest Universe Pharmaceuticals Inc seller in Q4 2022 was UBS Group, an estimated $9.27K sold.
Based on aggregated 13F filings for Q4 2022.